From the distinctive smell to therapeutic effects: Garlic for cardiovascular, hepatic, gut, diabetes and chronic kidney disease

Clin Nutr. 2021 Jul;40(7):4807-4819. doi: 10.1016/j.clnu.2021.03.005. Epub 2021 Mar 10.

Abstract

Garlic, a member of the Allium family, widely used in cooking for many centuries, displays well described antioxidant and anti-inflammatory properties, as a result of its constituent organosulfur compounds, such as alliin, allicin, ajoene S-allyl-cysteine, diallyl sulfide and diallyl disulfide, among others. Although garlic has demonstrated beneficial effects in cardiovascular disease, diabetes, and cancer, its efficacy as a therapeutic intervention in chronic kidney disease remains to be proven. This review thus focuses on the potential benefits of garlic as a treatment option in chronic kidney disease. and its ability to mitigate associated cardiovascular complications and gut dysbiosis.

Keywords: Chronic kidney disease; Garlic; Gut microbiota; Inflammation; Oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage*
  • Antioxidants / administration & dosage*
  • Cardiovascular Diseases / prevention & control
  • Dysbiosis / therapy
  • Garlic*
  • Gastrointestinal Microbiome / drug effects
  • Humans
  • Protective Agents / administration & dosage*
  • Renal Insufficiency, Chronic / therapy*

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Protective Agents